InvestorsHub Logo
Followers 278
Posts 32977
Boards Moderated 0
Alias Born 11/14/2013

Re: Ready4bluesky post# 35008

Monday, 05/25/2015 4:40:45 PM

Monday, May 25, 2015 4:40:45 PM

Post# of 717282
Nope, I'm saying that they both have trials against the same (current/then) standard of care control -- Stupps protocol. Novocure costs 252,000 per year, has more side effects than DCVax-L and DCVax-L will likely swamp Novocure's results against the (current/then) existing SOC (aka: Stupps protocol). (Even in the very unlikely case of an approximate tie with Novocure's earlier results, DCVax-L can also be approved because of superior safety and cost). The FDA does not have to postpone a decision for Novocure.

Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News